GGPOKER
26.4.2021 17:27:12 CEST | Business Wire | Press release
The World Series of Poker (WSOP) and GGPoker today announce a comprehensive schedule of online WSOP events kicking off with the WSOP Super Circuit Online Series on Saturday, May 1 and WSOP Online 2021 International tournament starting Sunday, Aug 1. Events open to international players will be hosted on the GGPoker app, while US players will enter via the WSOP.com online poker platform.
2021 WSOP Events at GGPoker and WSOP.com:
- WSOP Super Circuit Online Series at GGPoker - May 1-May 30
- WSOP Online 2021 (Domestic US) at WSOP.com - July 1-Aug. 1
- WSOP Online 2021 at GGPoker (International) - Aug. 1-Sept. 12
- WSOP Las Vegas “Main Event” satellites - Aug. 1-Oct. 1
- WSOP Winter Online Super Circuit at GGPoker - Dates TBC
WSOP action kicks off at GGPoker with the $100 million-guaranteed WSOP Super Circuit Online Series, scheduled from May 1 through May 30. A total of 18 WSOP Circuit ring events will headline the series, with a coveted WSOP Circuit gold ring awarded to each tournament’s winner. Furthermore, for the first time, an additional two WSOP Circuit rings will be awarded to cash game specialists; No-Limit Hold’em and Pot-Limit Omaha/Pot Limit Omaha-5 leaderboards will determine the invitation list for these two final-table-only events.
Dozens of WSOP gold bracelets will be up for grabs in the previously-announced WSOP 2021 Online series, which runs on WSOP.com for US players from July 1 through Aug. 1 and at GGPoker for international players from Aug. 1 through Sept. 12. A total of 33 bracelets will be won on WSOP.com, with the same number of bracelet tournaments at GGPoker. Last year’s WSOP Online Main Event at GGPoker was awarded the Guinness World Record for the largest prize pool in a single online poker tournament, boasting a massive $27.5 million in prizes.
Online satellite tournaments awarding tickets to the live World Series of Poker $10,000 No-Limit Hold’em World Championship, better known as “The Main Event®”, will also be hosted on WSOP.com and at GGPoker beginning Aug. 1. “The Main Event” is expected to begin on Nov. 4 in Las Vegas at the Rio All-Suite Hotel & Casino, and is the most famous live poker event on the planet. It has been held annually since 1970 and draws thousands of players from more than 100 countries, creating poker history with each new champion.
GGPoker will also host the WSOP Winter Online Super Circuit later in the year, with dates to be confirmed.
“The bar has been set with last year’s record-breaking series, but we’re hoping to raise it even higher this year,” said Gregory Chochon, Director of the World Series of Poker. “One of our goals is to provide as many people the chance to become champions as possible. However, we know not everyone can or is comfortable traveling yet, so continuing a robust online bracelet offering in 2021 is a must.”
Added GGPoker Head of Poker Operations Steve Preiss, “When GGPoker & WSOP partnered in 2020, we broke world records. Our plans for 2021 are to offer even more to our customers. With massive tournaments, WSOP gold bracelets & rings, and a route into the live WSOP Main Event in November, we hope players will love what we have in store for them.”
Full details on all online WSOP events will be released over the coming weeks and months, and will include tournament dates, buy-ins and other important information.
New GGPoker players are eligible to claim the poker room’s Welcome Bonus, earn additional rewards with the Honeymoon for Newcomers promotion and automatically join GGPoker’s Fish Buffet loyalty program, with regular cash prizes on offer.
For more information on the WSOP Super Circuit Online Series, please visit: https://en.ggpoker.com/tournaments/wsop-super-circuit-online-series/
About GGPoker : GGPoker is one of the world’s leading online poker rooms, with a global player base. It offers a range of innovative games and features such as the patented Rush & Cash poker, All-In or Fold, Flip & Go, Spin & Gold, integrated staking platform, SnapCam video messaging, the ability to squeeze your hole cards, PokerCraft, and Smart HUD, all designed to enhance gaming experiences and make poker more fun than ever. In 2020, GGPoker hosted WSOP tournaments, including the world record-breaking WSOP Online main event and the WSOP 2020 Main Event, while in April 2021, GGPoker hosts the $150M-guaranteed GG Spring Festival.
Find out more about GGPoker at GGPoker.com and on Facebook and Twitter .
About the World Series of Poker : The World Series of Poker® is the largest, richest and most prestigious gaming event in the world, having awarded more than $3.29 billion in prize money and the prestigious gold bracelet, globally recognized as the sport’s top prize. Featuring a comprehensive slate of tournaments in every major poker variation, the WSOP is poker’s longest-running tournament in the world, dating back to 1970. In 2019, the event attracted 187,298 entrants from 118 different countries to the Rio All-Suite Hotel & Casino in Las Vegas and awarded more than $293 million in prize money. In addition, the WSOP has formed groundbreaking alliances in broadcasting, digital media and corporate sponsorships, while successfully expanding the brand internationally with the advent of WSOP Europe in 2007 and the WSOP Asia-Pacific in 2013 and the WSOP International Circuit Series in 2015. For more information on the WSOP, please visit www.wsop.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210426005638/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom